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Cells form and use biomolecular condensates to execute biochemical reactions. The mole-
cular properties of non-membrane-bound condensates are directly connected to the amino
acid content of disordered protein regions. Lysine plays an important role in cellular function,
but little is known about its role in biomolecular condensation. Here we show that protein
disorder is abundant in protein/RNA granules and lysine is enriched in disordered regions of
proteins in P-bodies compared to the entire human disordered proteome. Lysine-rich poly-
peptides phase separate into lysine/RNA-coacervates that are more dynamic and differ at the
molecular level from arginine/RNA-coacervates. Consistent with the ability of lysine to drive
phase separation, lysine-rich variants of the Alzheimer’s disease-linked protein tau undergo
coacervation with RNA in vitro and bind to stress granules in cells. Acetylation of lysine
reverses liquid–liquid phase separation and reduces colocalization of tau with stress granules.
Our study establishes lysine as an important regulator of cellular condensation.
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Non-membrane-bound compartments, which enable thecoordination of intracellular reactions and processes,form and dissolve in response to cellular signals1. The
formation of non-membrane-bound compartments occurs pre-
dominantly through liquid–liquid phase separation (LLPS) of
macromolecules2–4. As a result of their liquid, gel-like, or solid
nature these phase-separated compartments are commonly
referred to as biomolecular condensates1,5. Intracellular phase
separation is driven by weak multivalent interactions between
proteins, typically containing disordered, low-complexity regions,
as well as RNA and DNA5–11. Important forces driving biomo-
lecular condensation include cation-π interactions between tyr-
osine from prion-like domains and arginine from RNA-binding
domains7, as well as coulombic interactions with negatively
charged phosphate groups of nucleic acids10,12,13. The molecular
properties of phase-separated compartments are further modu-
lated by glycine, which enhances droplet ﬂuidity, and glutamine
and serine, which promote droplet hardening7. In agreement with
an important role of post translational modiﬁcations in the reg-
ulation of biomolecular condensates14, LLPS is modulated by
phosphorylation of tyrosine15 and serine12,16, and methylation of
arginine17–20. One of the most highly post translationally mod-
iﬁed amino acid is lysine21. Despite the importance of lysine for
cellular function21, little is known however about the role of
lysine in biomolecular condensation.
Lysine with its lysyl ((CH2)4NH2) side chain is a basic and
positively charged amino acid at physiological pH. It inﬂuences
the function of proteins involved in development, cell–cell
interaction, signal transduction, and many other biological pro-
cesses21. In addition, lysine is often involved in histone mod-
iﬁcations and thus gene expression22. The ε-amino group of
lysine participates in hydrogen bonding and acts as a general base
in catalysis. The lysine side chain can be reversibly modiﬁed by
acetylation and other covalent modiﬁcations21. These modiﬁca-
tions generate binding motifs15, or increase/decrease the net
charge of the protein and thus tune the strength of biomolecular
interactions17. Post translational modiﬁcations of lysine side
chains are catalyzed by hundreds of enzymes and may lead to
changes in the activity and intracellular localization of proteins23.
The microtubule-associated protein tau is expressed in neurons
and aggregates into neuroﬁbrillary tangles in the brains of
patients with Alzheimer’s disease24. Tau is an intrinsically dis-
ordered protein25,26 and post translational modiﬁcations of tau
modulate tau/microtubule-interaction, tau localization, deposi-
tion, and neurotoxicity27. Alternative splicing produces six dif-
ferent isoforms of tau in the human central nervous system28.
The six tau isoforms differ in the number of N-terminal inserts
and have either three or four imperfect repeats in their C-
terminal half29. Lysine is one of the most abundant amino acids
in tau, can be acetylated by the acetyltransferases p300 and CBP,
and deacetylated by sirtuin 130. Tau also has intrinsic acetyl-
transferase activity31. Acetylation of tau is elevated in conditions
of cellular stress30, dysregulates tau homeostasis due to
acetylation-mediated blockage of tau polyubiquitylation30, inter-
feres with binding to microtubules32 and promotes synaptic
dysfunction33.
Tau can undergo LLPS and form liquid-like droplets34–37. The
strong increase in tau concentration within phase-separated tau
droplets enhances tubulin polymerization, recruits negatively
charged factors and promotes misfolding and aggregation34–37.
Binding to RNA and hyperphosphorylation promote tau phase
separation34–36. Tau pathology co-localizes with stress granules
(SG)38, cellular condensates that have been linked to neurode-
generative disease39. Tau accelerates SG formation, RNA-binding
proteins co-localize with tau inclusions40, and interference with
SG formation modulates tau pathophysiology41.
Here, we study the contribution of lysine to protein phase
separation and biomolecular condensation. Bioinformatic analy-
sis shows that lysine is enriched in disordered regions of proteins
in cytosolic protein/RNA granules when compared to the entire
human disordered proteome. We then use synthetic peptides with
distinct amino acid content to study molecular properties of
phase-separated states formed by lysine- and arginine-rich pep-
tides and show that different lysine-rich sequences of the protein
tau undergo complex coacervation with RNA and bind to SGs.
We ﬁnd that acetylation reverses lysine-driven peptide and pro-
tein LLPS and decreases association of tau with SGs. Our work
identiﬁes lysine as an essential molecular determinant of bio-
molecular condensation.
Results
Lysine is enriched in disordered regions of cytosolic granules.
Processing bodies (P-bodies) and SGs are non-membrane-bound
protein/RNA granules in the cytosol14. They contain at least 100
proteins, which interact with RNA42,43. To gain insight into the
nature of weak multivalent interactions in protein/RNA granules,
we predicted disorder with IUpred44 for three protein sets: the
entire human proteome, the proteins associated with P-bodies
and those associated with SGs, as measured by proteomics42. We
found that disordered regions are highly abundant in SGs and P-
bodies. Whereas 25% of amino acids in the total human proteome
are predicted to be disordered, the percentage is 35% for the SG
proteome and 38% for P-bodies. To see the relative importance of
disordered regions and their distribution across sequences, the
percent of residues predicted to be disordered in each protein in
the respective proteomes was plotted (Fig. 1a, Supplementary
Fig. 1a and Supplementary Data 1–3). Compared to the total
human disordered proteome, disordered regions in P-body-
associated proteins are most strongly enriched in K, a factor 1.3
above the human disordered proteome (p-value= 1.5E-28, one
sided t-test). Besides K, Y, and E are enriched, while H, P, and C
are most strongly depleted (Fig. 1b). In SGs, K is not enriched. Y
and F are most strongly enriched, while H, L, and P are most
strongly depleted (Supplementary Fig. 1b).
To further understand the compositional properties of
disordered regions in protein/RNA granules, we calculated
dipeptide frequencies. P-bodies and SGs displayed consistent
enrichment of GG, PP, SS, and RR dipeptides (Fig. 1c and
Supplementary Fig. 1c). Among hetero-dipeptides, RG, RS, and
SR are most enriched in P-bodies and SGs, KE, and KR are more
strongly enriched in P-bodies than in SGs (Fig. 1c and
Supplementary Fig. 1c). Finally, we analyzed the pairwise
distances between selected amino acids in the disordered regions
of the entire human disordered proteome, in P-bodies and SGs.
Same-charged pairs such as K-K and E-E show a marked
tendency to cluster locally in sequence in P-bodies and SGs,
whereas amino acids with opposite charges do not (Fig. 1d and
Supplementary Fig. 1d). This observation is in accordance with
interactions between clusters of oppositely charged residues
participating in liquid droplet formation6.
Lysine-rich condensates are highly dynamic complex coa-
cervates. The bioinformatic analysis showed that lysine occurs
with high frequency in cytosolic protein/RNA granules. As the
formation of protein/RNA granules has been connected to LLPS
and coacervation of disordered proteins with RNA, we investi-
gated if lysine-rich polypeptide sequences phase separate in the
presence of RNA. To this end, we selected the arginine-rich
peptides R2 and R3, which contain either two (R2) or three
RRASL sequences (R3) and were previously shown to undergo
complex coacervation with RNA12. In addition, we synthesized
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10792-y
2 NATURE COMMUNICATIONS |         (2019) 10:2909 | https://doi.org/10.1038/s41467-019-10792-y | www.nature.com/naturecommunications
the peptides K2 and K3 that only differ by the type of positively
charged side chain, i.e., lysine vs. arginine, and have otherwise
identical amino acid sequences when compared to R2 and R3,
respectively (Fig. 2a and Supplementary Fig. 2a). We then pre-
pared peptide solutions with transfer RNA (tRNA) or polyU RNA
(Fig. 2b) at different peptide concentrations and pH values and
found that the mixtures underwent phase separation when K3/R3
concentrations reached ~ 0.5 mM (Fig. 2b, c and Supplementary
Fig. 2b). The condensation-transition led to the occurrence of
spherical droplets that fused with each other (Fig. 2b and Sup-
plementary Movie 1), indicative for their liquid-like nature1–3,5.
At equal peptide concentrations R2 phase-separated but not K2
(Supplementary Fig. 2b) and R3 solutions were more turbid and
less sensitive to high pH compared to K3 (Fig. 2c). The K3
droplets grew in time at the expense of smaller droplets (Fig. 2d).
The number and average size of K3 and R3 droplets increased
with increasing tRNA concentration (Fig. 2e and Supplementary
Fig. 2c, d), and K3 droplet formation was inhibited upon addition
of 30 mM NaCl (Supplementary Fig. 2e), conﬁrming that LLPS
occurs as a complex coacervation between the positively charged
K3/R3 and negatively charged RNA chains1,2,5. Addition of low
concentrations of ﬂuorescently labeled K3 to a solution of pre-
formed R3/RNA droplets further demonstrated that lysine-rich
sequences can be recruited to arginine/RNA-coacervates (Sup-
plementary Fig. 2f).
Fluorescence recovery after photobleaching (FRAP) showed
that the interior of lysine- and arginine-rich droplets is liquid-like
(Fig. 2f) and allows rapid exchange of droplet-embedded
molecules with the surroundings. In case of R3, the FRAP
kinetics were accurately described by a diffusion-controlled
recovery model45 yielding a diffusion coefﬁcient of D= 0.31
µm2 s-1 with a Bayesian information criterion BIC(Axelrod)=
−107546. As a ﬁt of the experimental data assuming an
exponential recovery model resulted in a BIC(exponential)=
−756, we conclude that the Axelrod model is more appropriate to
describe the diffusional properties of R3. In contrast, much faster
recovery was observed for K3 and its kinetics were better
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Fig. 1 Disordered protein regions in P-bodies are rich in lysine. a Distribution of the fraction of disorder predicted by IUpred for P-body proteins (top) and
the entire human proteome (bottom). b Box plot of log2-fold enrichment of amino acids in disordered regions of P-bodies relative to disordered regions of
the entire human proteome. Boxes and whiskers show, from bottom to top, 5%, 25%, 50%, 75%, and 95% quantiles. Red/blue: positively/negatively
charged residues. p-values < 10−5:*, < 10–10:**, < 10–20:***. c Log2 enrichment (red) or depletion (blue) of dipeptides in disordered regions of P-bodies
relative to disordered regions of the entire human proteome. First residue on x-axis, second on y-axis. Size of circles: total probability of dipeptide (sum=
1). d Same charges cluster together in P-bodies, while opposite charges do not. Top: Total counts of amino acid K at position x relative to an E at position 0
(ﬁrst residue) in disordered regions of P-bodies. Virtually no clustering is observed. Middle and bottom: Same for K/K and E/E instead of K/E. Residues of
same charge are enriched within+ /− 5 residues of each other. Source data are provided as a Source Data ﬁle
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10792-y ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2909 | https://doi.org/10.1038/s41467-019-10792-y | www.nature.com/naturecommunications 3
0.63 s (Fig. 2f) with a BIC(exponential)=−821, whereas BIC
(Axelrod)=−652. To provide further support for the distinct
diffusional properties of lysine and arginine-rich polypeptide
sequences in RNA-mediated droplets, we prepared the hybrid
peptide K2R1, which consists of two KKASL and one RRASL
repeat, and formed droplets through addition of RNA. FRAP
analysis showed that the kinetics of ﬂuorescence recovery are in-
between those of K3 and R3 (Fig. 2f). In addition, the recovery
kinetics of K2R1 were better described by an exponential recovery
with a half time of 1.2 s (BIC(exp)=−635), whereas an Axelrod
RNA
Liquid droplets

























































































































Fig. 2 Complex coacervation of lysine-rich polypeptides. a Amino acid sequences of the lysine-rich (K3) and arginine-rich peptide (R3) along with a
schematic of complex coacervation upon addition of RNA. b (left) Comparison of the turbid (phase-separated) peptide-containing sample and the control
sample/buffer. (Right) DIC image of a pair of K3/RNA liquid droplets undergoing fusion. The concentration of polyU RNA was 0.5 mgml−1 and K3 was
1 mM. c Turbidity of K3 with tRNA (0.5 mgml−1) and R3 with tRNA (0.5 mgml−1) samples at different pH values and peptide concentrations (0.1 mM,
0.5 mM, and 1 mM). Reported turbidity values represent the average of a triplicate of measurements for each sample. d Distribution of droplet diameters
after 5 and 20min with the corresponding ﬂuorescence images. The concentration of polyU RNA was 1 mgml−1. e DIC and ﬂuorescence images depicting
the tRNA concentration-dependence of K3 (top) and R3 (bottom) coacervation. Scale bars, 10 μm. f Normalized FRAP recovery curves (left) for K3/RNA-
coacervates, K2R1/RNA-coacervates and R3/RNA-coacervates with the corresponding FRAP images (right; recovery image 27.2 s after bleaching; scale
bar 1 μm). Fits to the experimental data assuming an exponential recovery (K3, K2R1; solid line) and diffusion-controlled recovery (R3; Axelrod model,
dash-dotted line). The concentration of K3, K2R1, R3, and polyU RNA in DIC, ﬂuorescence imaging, and FRAP were identical and equal to 1 mM K3/K2R1/
R3 and 1 mgml−1 polyU RNA, in 50mM HEPES, pH 7.4. TMR-K3, TMR-K2R1 and TMR-R3 were used as speciﬁed in the methods section. Error bars in
c and f correspond to ± SD. Source data are provided as a Source Data ﬁle
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ﬁt could not describe the data at times longer than 10 s (BIC
(Axelrod)=−598). Thus, the lysine residues appear to dominate
the diffusional properties of K2R1. The combined data suggest a
more open and less entangled molecular mesh in lysine-rich
condensates.
Lysine/RNA-coacervates differ from arginine/RNA-coa-
cervates. We then used nuclear magnetic resonance (NMR)
spectroscopy to assess the molecular properties of lysine- and
arginine-rich coacervates. One-dimensional 1H spectra displayed
decreased signal intensities and line-broadening upon mixing R3
with RNA (Supplementary Fig. 3a), potentially a result of atte-
nuated motional narrowing upon interaction of the peptide with
RNA. LLPS-induced line-broadening in 1H-detected NMR spec-
tra was previously observed for several intrinsically disordered
proteins17,34,47,48. In case of R3/RNA-coacervates, no additional
speciﬁc features beside signal broadening were detected (Sup-
plementary Fig. 3a). In contrast, new NMR signals were observed
when mixing K3 with RNA (Fig. 3a and Supplementary
Fig. 3b–d). Resonances speciﬁc for lysine/RNA-interactions were
detected in the leucine Cδ region near ~ 0.6 ppm, and also at
~7.28 ppm and ~ 8 ppm (see peaks marked with * in Fig. 3a).
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Fig. 3 NMR spectroscopy and temporal stability of lysine-driven condensation. a 1D 1H NMR spectra of the lysine-rich peptide K3 (1 mM; blue), K3
with polyU RNA forming liquid droplets (1 mM K3 and 1 mgml−1 polyU RNA; black) and the same sample after 24 h (red), as well as polyU RNA alone
(1 mgml−1; green). Peptide NMR signals, which are characteristic for the interaction with polyU RNA, are marked with asterisks. b 2D 1H−13C HSQC NMR
spectrum of K3 (blue) and K3 with polyU RNA (orange). Cross-peaks were labeled according to amino acid-speciﬁc chemical shift values. The two K3/
RNA-speciﬁc NMR signals at 1H frequencies of 0.53 and 0.59 ppm (marked with asterisks in a) were also present in the 2D 1H-13C HSQC NMR spectrum
and have identical 13C chemical shifts as the two leucine Cδ resonances of K3 in the absence of polyU RNA. c Temporal stability of K3 droplets as
monitored by the time-dependent decrease of NMR signals. (Top) 1D 1H NMR spectra of K3 at 0, 1, 2, 3, 4, 5, 6, and 7 h with K3/RNA-speciﬁc signals
labeled from a–e. (Bottom) Time-dependent decrease in normalized signal intensity of K3/RNA-speciﬁc signals. Error bars are based on signal-to-noise
ratios in the NMR spectra. The peptide solution became clear after ~ 7 h. d DIC micrographs of a sample containing K3 (1 mM) and polyU RNA (1 mgml−1)
over a period of 8 h. Liquid droplets disappeared after about 7–8 h. Scale bar, 10 μm
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Two-dimensional 1H-13C heteronuclear single quantum coher-
ence spectra showed that the two lysine/RNA-characteristic 1H
resonances at ~ 0.6 ppm couple to leucine Cδ resonances
(Fig. 3b), indicating that these new resonances are a result of the
different chemical environment of the two protons in the free and
RNA-bound form. Notably, hydrophobic interactions of leucine
residues49 and hydrogen bonding between serine side-chains and
the peptide backbone50 stabilize helical conformations in short
peptides and proteins. In addition, we observed that the speciﬁc
1H signals at ~ 8 ppm coupled to Hα protons in a two-
dimensional total correlation spectrum (Supplementary Fig. 3d).
Further NMR measurements at different peptide and RNA con-
centrations, as well as increasing ionic strengths, showed that the
new NMR signals are visible in both the dispersed phase (e.g., at
low peptide concentration) and the phase-separated state (Sup-
plementary Fig. 4). The observation of peptide signals speciﬁc for
the interaction with RNA in case of K3 but not R3 suggests that
arginine more strongly interacts with RNA when compared to
lysine, in agreement with the observed differences of K3 and R3
to form liquid-like droplets in the presence of RNA (Fig. 2).
The intensity of the lysine/RNA-speciﬁc NMR signals decayed
in time and disappeared after ~ 7 h (Fig. 3c). In parallel,
differential interference contrast (DIC) microscopy showed that
the number of observable droplets gradually decreased during this
time (Fig. 3d). In case these observations would be the result
of the reversible dissociation of droplets, it would be expected that
the NMR spectra would become similar to those observed at the
same peptide/RNA-ratio but an overall lower peptide concentra-
tion, i.e., in conditions in which no droplets are formed
(Supplementary Fig. 4). Instead we found that both the K3
NMR signals and the polyU RNA resonances decreased. This
points to an irreversible process resulting in the sedimentation of
droplets or precipitation of K3/RNA-complexes.
RNA-mediated phase separation of tau sequences. To gain
further insight into the importance of lysine for biomolecular
condensation, we investigated the phase behavior of solutions of
lysine-rich sequences of the Alzheimer-related protein tau. To
this end, we prepared the full-length 441-residue isoform of tau
(hTau40), the projection domain of tau comprising the N-
terminal 184 residues (termed K25), as well as tau’s repeat
domain (termed K18; Fig. 4a). Different concentrations of polyU
RNA were selected based on the pI of the corresponding tau
sequences. We found that all three tau sequences undergo LLPS
in a concentration-dependent manner via complex coacervation
with polyU RNA (Fig. 4b). hTau40, which contains a total of 44
lysine and 14 arginine residues and has the lowest pI= 8.24
among the three, required the smallest amount of RNA to phase
separate (Fig. 4b, left column). The highest concentration of RNA
was required for K18, which contains 20 lysines and 1 arginine
and has a pI= 9.73 (Fig. 4b, left column; Supplementary Fig. 5a).
hTau40 not only phase-separated with RNA, but also without
RNA in the presence of dextran as a crowding agent (Fig. 4b,
middle column; and Supplementary Fig. 5b) or in HEPES buffer
(Fig. 4b, right column), likely because of the ampholytic nature of
the amino acid sequence of full-length tau.
Phase-separated droplets of tau formed with polyU RNA
were spherical, fused and grew at the expense of smaller
droplets (Fig. 4b, c and Supplementary Movie 2 and 3). Phase
separation of K18 with RNA was reversed upon increasing the
ionic strength of the solution (Supplementary Fig. 5c), while
addition of aliphatic alcohols (1,6- or 2,5-hexanediol) did not
dissolve tau and K3/RNA droplets (Supplementary Fig. 5e).
However, dextran-promoted hTau40 droplets did not grow
during the observation phase (Fig. 4c, bottom panel), and salt
concentrations < 100 mM NaCl promoted hTau40 droplets (Sup-
plementary Fig. 5d), suggesting a different mechanism of phase
separation when compared to tau/RNA complex coacervation.
To assess the molecular mobility of hTau40 and K18 within
droplets, we formed droplets of both proteins using identical
concentrations of polyU RNA (Fig. 5a). Subsequent FRAP analysis
revealed a diffusion-controlled recovery with a signiﬁcantly higher
diffusion coefﬁcient of K18 (D(K18)= 0.007 μm2 s−1) as
compared to hTau40 (D(hTau40)= 0.002 μm2 s−1) (Fig. 5b).
Statistical analysis resulted in BIC(Axelrod) values of −459 and
−346 for hTau40 and K18, respectively, whereas BIC(exponential)
values were −445 and −289 for hTau40 and K18, respectively.
The faster diffusion of K18 within the droplets is consistent with
the higher relative abundance of lysine when compared to arginine
(15% K and 0.8% R in K18 compared to 10% K and 3% R in
hTau40).
Acetylation reverses lysine-driven liquid–liquid phase separa-
tion. In vivo, lysine is extensively post translationally modiﬁed by
acetylation21. To determine if acetylation inﬂuences lysine-driven
condensation, we acetylated the lysine-rich peptides and tau
sequences with lysine acetyltransferase (KAT) p300 or CREB in
the presence of acetyl-Coenzyme A (AcCoA) (Fig. 6a, b and
Supplementary Fig. 6a, b). Mass spectrometry identiﬁed two and
three acetylated groups in K3 (Supplementary Fig. 6a, b), and a
mixture of 5-, 6-, 7-, 8-, and 9-fold acetylated K18, and 12 out of
44 acetylated lysines in hTau40 (Fig. 6b).
DIC and ﬂuorescence microscopy revealed that acetylation
results in gradual shrinking and ultimately dissolution of
coacervates of hTau40 formed in presence of dextran, or of
K18 coacervates formed with RNA (Fig. 6c). In case of hTau40,
droplets had disappeared already after ~ 10 min, while droplets
were no longer visible after ~ 25 min for K18 (Fig. 6c).
Quantiﬁcation of solution turbidity at 500 nm further showed
that after 25 min the K18 droplets had not yet fully dissolved, but
were too small to be detected by microscopy. After ~ 1 h, K18/
RNA solutions were fully transparent (Fig. 6d, right panel).
Control experiments in the absence of CREB or in the absence of
AcCoA demonstrated that K18/RNA droplets or dextran-
promoted hTau40 droplets dissolution was speciﬁc for lysine
acetylation (Fig. 6d and Supplementary Fig. 6c, d). The speciﬁcity
of acetylation-dependent complex coacervation was further
supported by KAT reactions with lysine- and arginine-rich
peptide/RNA-coacervates (Fig. 6e), demonstrating that R3/RNA-
coacervates are not dissolved in the presence of CREB or p300.
In order to gain insight into how acetylation interferes with
protein/RNA LLPS, we performed NMR titrations of wild-type
and acetylated hTau40 (Fig. 7a, b) in the presence of different
concentrations of tRNA. We observed pronounced changes in the
chemical shifts of many residues in 2D 1H-15N correlation
spectra of hTau40 upon increasing concentration of tRNA
(Fig. 7c and Supplementary Fig. 7). Sequence-speciﬁc analysis
revealed that the chemical shift perturbations predominantly
occur in the central part of hTau40 from residues ~ 123–386,
which contains most of the lysine and arginine residues and
carries a net positive charge at pH 7.4 (Fig. 7d). Comparison of
chemical shift changes induced by equal concentrations of tRNA
in wild-type and acetylated hTau40 demonstrated that tRNA
causes smaller perturbations in the acetylated protein (Fig. 7e),
which is indicative for a decreased afﬁnity of tRNA to acetylated
hTau40. The observation of an attenuated but not inhibited
interaction is in agreement with the ﬁnding that not all lysine
residues of htau40 where acetylated by CREB (Fig. 7a, b). In
addition, arginine residues, which are not affected by acetylation,
will further contribute to the interaction of hTau40 with tRNA.
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Acetylation reduces co-localization of tau with stress granules.
Tau protein co-localizes with stress granules (SGs)
in vivo38,41,51,52. To investigate the importance of lysine for co-
localization of tau with SGs, we analyzed different tau sequences
and acetylated tau for their binding to SGs in semi-permeabilized
Hela cells18 (see schematic in Fig. 8a). Here, SGs were induced by
the proteasome inhibitor MG132 and the plasma membrane of
cells was subsequently selectively permeabilized by digitonin.
Soluble cytosolic factors were washed out and nuclear pore
complexes blocked with wheat germ agglutinin (WGA). Next,
equal amounts of recombinant, ﬂuorescently labeled tau proteins
were added and after extensive washing, SGs were visualized by
immunostaining against the SG marker proteins G3BP1 or TIA-
1. Fluorescence microscopy showed that MG132 induced robust
formation of SGs, which stained for both G3BP1 and TIA-1
(Fig. 8b–d). In addition, all three tau constructs (hTau40, K25 and
K18) co-localized with SGs, but to a different extent (Fig. 8b).
Quantiﬁcation further showed that K25 most strongly associates
with SGs (Fig. 8c and Supplementary Fig. 8a). K18 and hTau40
had similar levels of SG co-localization, although slightly higher
ﬂuorescence intensity was on average observed for hTau40 when
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Fig. 4 Inﬂuence of tau domain structure and co-factors on LLPS. a Domain organization of hTau40, K25, and K18. N1 and N2 are the two inserts not present
in K25, P1, and P2 the two proline-rich regions, and R1–R4 the four pseudo-repeats. The pI and the number of lysine (K) and arginine (R) residues in
hTau40, K25 and K18 are indicated. b DIC and ﬂuorescence micrographs of hTau40, K25, and K18 solutions in the presence of different co-factors/buffer
conditions. The concentration of the proteins was 50 μM. c Droplet size distribution of K18 (top) and hTau40 (bottom) after ﬁve and 20min alongside
corresponding ﬂuorescence images. K18 (50 μM) with 125 µg ml−1 polyU RNA in 25mM HEPES, pH 7.4, was used. For hTau40 (50 μM), the same buffer
was used with 10% dextran (and no RNA). Scale bar, 10 μm
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when compared to K18 was supported through ﬂuorescent
labeling of the two native cysteine residues (Cys291 and Cys322)
in tau (Supplementary Fig. 8b). The ﬁnding that co-localization of
tau with SGs decreases in the order K25 > hTau40 > K18 suggests
that the repeat region of tau has an inhibitory effect on the co-
localization of tau with SGs.
To systematically assess the role of lysine and arginine for co-
localization with SGs, we also performed experiments with the
model peptides R3, K2R1, and K3 (Supplementary Fig. 9).
Addition of the ﬂuorescently labeled peptides to the semi-
permeabilized cells showed that their SG co-localization decreases
in the order R3 > K2R1 > K3. SG co-localization thus decreased
with decreasing arginine content. Notably, the relative abundance
of arginine also decreases in the order K25 > hTau40 > K18 (6% >
3% > 0.8%), suggesting a correlation between relative arginine
content and SG co-localization.
In vitro experiments showed that acetylation inhibits tau
LLPS53 (Fig. 6). To determine if acetylation also inﬂuences co-
localization of tau with SGs, we acetylated full-length tau protein
and compared it to unmodiﬁed hTau40 in the SG association
assay (Fig. 8d). In multiple, independent experiments the
ﬂuorescence intensity of acetylated hTau40 was comparable to
background ﬂuorescence intensity (Fig. 8e), indicating that
acetylation strongly reduces association of tau with SGs.
Discussion
Cells form and use non-membrane-bound compartments/bio-
molecular condensates to execute and regulate biochemical
reactions1,5. The formation of protein/RNA granules and other
biomolecular condensates depends on weak multivalent interac-
tions between a large number of molecules5,6. Because of their
dynamic nature, intrinsically disordered proteins are powerful
drivers of LLPS and biomolecular condensation3,5–8. The multi-
valent and cooperative process of LLPS is intimately connected
to the amino acid composition of disordered regions in
proteins3,5–8,10. In addition, the molecular properties of biomo-
lecular condensates and their ability to enable and modulate
biochemical reactions are linked to their physico-chemical char-
acteristics and thus to the type and distribution of amino acids in
condensed disordered proteins3,5–7,10.
To gain insight into the physico-chemical properties of bio-
molecular condensates, we analyzed the amino acid content of
cytosolic protein/RNA granules (Fig. 1). Bioinformatic analysis
shows that protein disorder is more abundant in proteins asso-
ciated with SGs and P-bodies than in the entire human proteome
(Fig. 1). In addition, the amino acid content in disordered regions
of proteins associated with SGs and P-bodies differs from each
other, as well as from the human disordered proteome. Lysine is
abundant in protein/RNA granules and is the most enriched
amino acid in P-bodies when compared to the human disordered
proteome (Fig. 1). Lysine can therefore play an important role in
the process of biomolecular condensation and modulate the
properties of protein/RNA granules.
Supporting a functional role of lysine in biomolecular con-
densation (Fig. 1), we show that designed lysine-rich peptides
phase separate in the presence of RNA (Fig. 2). The resulting
liquid-like droplets are more dynamic (Fig. 2) and differ in their
molecular properties from arginine/RNA droplets (Fig. 3 and
Supplementary Fig. 3). The distinct molecular properties of
coacervates formed by lysine- and arginine-rich peptides origi-
nate from differences in the chemical structure of the two side
chains. Although lysine has a lower pKa (10.5 vs. 13.8 for argi-
nine54), both will be fully dissociated at physiological pH and thus
carry the same charge. When embedded in a peptide or protein
the effective pKa of the arginine residue, however, can potentially
be higher due to the larger intrinsic pKa and result in altered
dissociation equilibria. In addition, the electron cloud is deloca-
lized across the planar guanidinium group of arginine55, which
introduces directional preferences for cation-pi interactions with
aromatic groups, such as tyrosine and phenylalanine, a potential
reason for the importance of arginine-tyrosine interactions for
LLPS of RNA-binding proteins with prion-like low-complexity
domains7,17,56–58. The tetrahedral ammonium cation in lysine
has a more spherically symmetric charge distribution with weaker
directional preferences55,59. In addition, the number and nature
of hydrogen bonds formed by the ammonium and guanidinium
cations with the phosphate anion differ. The side chain of lysine
can form more hydrogen bonds than the one of arginine, but in
contrast to the guanidinium case with almost perfectly co-linear
N−H···O atoms, N−H···O angles with lysine side chains are
distorted to 120°60,61. Alternatively, lysine forms only one
hydrogen bond but with the energetically optimally aligned N
−H···O60. These effects are expected to lead to stronger interac-
tions of arginine with RNA and can account for the more
cohesive nature of arginine-rich condensates as compared to
lysine-rich peptides, in agreement with the more rapid diffusion
observed in K3 and K2R1 droplets when compared to R3 droplets
(Fig. 2f) and a higher mobility of a peptide comprising 30 proline-
lysine dipeptides in RNA-induced droplets when compared to a
30 proline-arginine repeat peptide11. High-permeability con-
densates were observed in LAF-1 droplets and were suggested to
allow for size-selective ﬁltering analogous to FG nucleoporins in
the nuclear pore62.
The interactions between arginine- and lysine-containing
polypeptides and nucleic acids also depend on the length of the
peptide, salt concentration, the peptide/nucleic acid molar ratio

























Fig. 5 Dynamics of tau in tau/RNA droplets. a FRAP images (recovery
image 129 s after bleaching; scale bar 1 μm). b Normalized FRAP recovery
curves for hTau40 (50 µM; gray) and K18 (50 µM; red) droplets in the
presence of 40 µg ml−1 polyU RNA (25mM HEPES, pH 7.4). Symbols with
error bars depict experimental results; black lines are ﬁts assuming
diffusion-controlled recovery (i.e., the Axelrod model). Error bars in b
correspond to ± SD. Source data are provided as a Source Data ﬁle
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experimental conditions these interactions can give rise to
reversible non-speciﬁc ionic interactions or speciﬁc, stoichio-
metric (i.e., completely charge-neutralizing), cooperative and
virtually irreversible interactions that eventually can lead to
precipitation63,64,66, with arginine generally displaying a much
stronger precipitation tendency63,67. It is therefore conceivable
that a competition between ‘classical’’ polyelectrolyte coacerva-
tion and condensation driven by speciﬁc peptide/RNA-interac-
tions is responsible for the phase behavior observed in the present
study, with peptide/RNA-interactions initially driving condensa-
tion via complex coacervation, which due to speciﬁc cooperative
peptide/RNA-interactions eventually lead to gradual precipitation
of an irreversible stoichiometric complex that is invisible in NMR
experiments and is observed in terms of a decay of peak inten-
sities characteristic for speciﬁc peptide/RNA-interactions (Fig. 3).
Fluorescence microscopy and NMR spectroscopy showed that
lysine/RNA-interactions differ from arginine/RNA-interactions
resulting in distinct molecular properties in protein/RNA droplets
(Figs. 2 and 3). Lysine residues in disordered protein regions can
therefore provide a distinct environment in the interior of bio-
molecular condensates. In cases where arginine/RNA-interactions
dominate the process of condensation, lysine would inﬂuence the
nature of biochemical reactions within the condensate. In addi-

















































































































































































































Fig. 6 Acetylation reverses lysine-driven coacervation. a Cartoon representation illustrating acetylation of lysine-rich polypeptides by lysine
acetyltransferase (KAT) in the presence of acetyl-Coenzyme A (AcCoA) (left) and its inﬂuence on lysine/RNA coacervation (right). bMass spectra of K18
and hTau40 samples before (top) and after acetylation by CREB (bottom). Identiﬁed masses (in Da) are indicated. c DIC and ﬂuorescence images show
dissolution of K18/RNA (top; 50 µM K18, 125 µg ml−1 polyU RNA in 25mM HEPES, pH 7.4) and hTau40/dextran (bottom; 50 µM hTau40, 10% dextran in
25mM HEPES, pH 7.4) droplets in the presence of the acetyltransferase CREB and AcCoA. Time-dependent changes in droplet numbers were quantiﬁed
(left). Experiments were performed three times for each protein sample. d, e Turbidity measurements of K18 (50 µM; d), as well as arginine- (R3; 1 mM)
and lysine-rich (K2 and K3; 1 mM) peptides (e), which underwent LLPS through addition of polyU RNA (125 µg ml-1 for K18, 0.5 mgml-1 for the peptides), in
the presence of either CREB/p300 or AcCoA, or both the enzyme and AcCoA. In the middle, photographs of the respective K18 samples after 60min are
depicted. Reported values represent an average of three independent samples. Error bars in d and e correspond to ± SD. Source data are provided as a
Source Data ﬁle
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regions of condensed proteins can provide a strategy to optimize
the afﬁnity for a given protein or nucleic acid, which in pure
arginine condensates would have too high afﬁnity.
Previous studies have established a link between the
microtubule-associated protein tau and SGs38,41,51,52. In addition,
LLPS of tau results in supersaturation of tau in liquid-like dro-
plets, which provide an environment that can recruit negatively
charged co-factors and promote misfolding and pathogenic
aggregation of tau34,36. The role of individual domains of tau for
cellular condensation has however been largely unknown. We
show that wild-type tau can phase separate at high protein con-
centrations into liquid-like droplets at physiological pH, either
alone or in presence of RNA (Fig. 4b). The N-terminal projection
domain and the repeat region of tau can also independently phase
separate with RNA (Fig. 4b). All three tau sequences contain a
large number of lysine residues. In particular, the repeat region
construct K18 has 20 lysine residues but only 1 arginine and can
undergo self-coacervation at pH 8.834, as well as complex coa-
cervation with RNA at physiological pH (Fig. 4b). All three tau
variants associate with SGs when added to semi-permeabilized
cells (Fig. 8b). The strongest SG association was observed for K25,
which lacks the repeats, followed by hTau40 and K18 (Fig. 8c).
This suggest that the repeat region has an inhibitory effect on the
SG association of tau. In addition, changes in the binding prop-
erties to cytosolic proteins such as microtubules and chaperones
could contribute to differences observed in the association of
different tau domains with SGs.
Acetylation of lysine side chains is an important cellular
modiﬁcation of proteins21,23. We showed that in a synthetic
lysine-rich peptide with designed amino acid content, acetylation
reverses coacervation with RNA and can thus be speciﬁcally
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Fig. 7 Acetylation weakens binding of tau to RNA. a Domain organization of hTau40. The location of its 44 lysine residues is marked by arrows. b Mass
spectra of 15N-labeled hTau40 (left) and 15N-labeled hTau40 acetylated by CREB (right). Identiﬁed masses (in Da) are indicated. Tau is acetylated at up to
14 sites. c Superposition of selected regions of 2D 1H-15N spectra of hTau40 (top, black) and acetylated hTau40 (bottom, gray), respectively, for increasing
molar ratios of tRNA: 0.25 (cyan), 0.5 (orange) and 1 (green). d Averaged 1H,15N chemical shift perturbations (CSP) of resonances in 2D 1H-15N HSQC
spectra of hTau40 caused by binding to tRNA (color code as in c). The net charge of different domains of hTau40 is illustrated on top. Arrows mark lysine
and arginine residues. e CSP of resonances in 2D 1H-15N HSQC of hTau40 (black) and acetylated hTau40 (gray) caused by the addition of an equimolar
concentration of tRNA (see also b)
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addition, we demonstrated that acetylation of different regions of
tau dissolves liquid-like tau droplets formed in presence of a
molecular crowding agent (Fig. 6c), in agreement with previous
results53, but also tau K18 droplets formed through coulombic
interactions with RNA (Fig. 6c, d). Besides the frequency and
distribution of lysine residues in disordered proteins (Fig. 1),
lysine acetylation might thus inﬂuence the composition and
molecular properties of biomolecular condensates. Consistent
with this hypothesis, the lysine acetyltransferase CBP and lysine
deacetylases HDAC6 and SIRT6 co-localize with SG proteins in
mammalian cells68–70, pharmacological inhibition or genetic
ablation of HDAC6 can abolish SG formation69, deacetylation of
the RNA helicase DDX3X by HDAC6 is necessary for SG
maturation71 and acetylation of DDX3X interferes with its ability
to undergo phase separation71. Acetylation of TDP-43, a RNA-
binding protein that is found in SGs72, undergoes LLPS
in vitro8,9,47 and aggregates into insoluble deposits in the brain of
patients with amyotrophic lateral sclerosis and frontotemporal
lobar degeneration73, promotes TDP-43 aggregation into SGs,
while HDAC6-dependent deacetylation of TDP-43 reduces SG
formation70. In case of the Alzheimer’s disease-related protein
tau, we ﬁnd that its acetylation inhibits LLPS and reduces/sup-
presses co-localization with SGs (Fig. 8d, e). As acetylation of tau
increases tau-induced neurotoxicity30,33,74, decreased association
of acetylated tau with SGs suggests a potential neuroprotective
role of SGs in the context of tau-related neurotoxicity. Such a
SG
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Fig. 8 Inﬂuence of tau domains and lysine acetylation on SG association of tau. a Schematic diagram illustrating the semi-permeabilized cell assay. After SG
induction by MG132, the plasma membrane of Hela P4 cells is selectively permeabilized using digitonin, cytosolic soluble factors are washed out and
subsequently nuclear pore complexes blocked by WGA. Next, Alexa 488-labeled tau proteins are incubated with semi-permeabilized cells to allow binding
to SGs and after extensive washing, SGs were subjected to immunostaining for the SG makers G3BP1 and TIA-1. b SG association of K18, K25, and hTau40
(400 nM; degree of labeling (“DOL corrected”)= 3.7), scale bar, 10 μm. In the merge, Alexa 488 ﬂuorescence (green) and TIA-1 staining (red) are shown.
c Quantiﬁcation showing the Log2-transformed mean ﬂuorescence intensity of K18, K25, and hTau40 vs. background (bkgr) in SGs. Four replicates with at
least 8–10 cells and≥ 25 SGs each are shown. Error bars correspond to ± SEM. d SG association of unmodiﬁed hTau40 (400 nM; DOL= 1.0) in
comparison to acetylated hTau40 (Ac-hTau40) monitored by Alexa 488-ﬂuorescence. In the merge, Alexa 488 ﬂuorescence (green) and TIA-1 staining
(red) are shown. e Quantiﬁcation showing the Log2-transformed mean ﬂuorescence intensity of hTau40 and Ac-hTau40 vs. background in SGs. Four
replicates with at least 8–10 cells and≥ 37 SGs each are shown. Error bars correspond to ± SEM. Please note, that due to the wide range of ﬂuorescence
intensities of the recombinant proteins in SGs, different laser settings had to be used in b when compared to d in order to avoid pixel saturation and to
ensure ideal representation of the differential SG recruitment of the different proteins. Source data are provided as a Source Data ﬁle
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neuroprotective mechanism could involve the transient trapping
of non-acetylated, aggregation-competent tau in SGs.
The ability of many enzymes to post translationally modify
lysine residues23 provides further opportunities to inﬂuence and
regulate lysine-driven biomolecular condensation. Ubiquitination
of lysine is a major determinant for protein degradation75 and
protein deubiquitination by the deubiquitinase enzyme Ubp3
promotes assembly of SGs76. Targets of deubiquitinases or
ubiquitin-conjugating enzymes might be low-complexity regions
of proteins located in SGs and P-bodies, which our bioinformatic
analysis have been shown to be rich in lysine residues (Fig. 1).
Attachment of ubiquitin chains to lysine residues in disordered
regions are expected to sterically interfere with the weak multi-
valent interactions that are required for LLPS and biomolecular
condensation.
In summary, our integrative approach comprising bioinfor-
matic analysis, in vitro phase separation studies, ﬂuorescence
microscopy and NMR spectroscopy, together with a cellular SG
association assay, establishes lysine as a critical regulator of bio-
molecular condensation.
Methods
Selection of proteins for bioinformatic analysis. For analysis of the amino acid
content in disordered regions of SGs and P-bodies, protein data sets determined by
Jain et al.42 and Hubstenberger et al.43 were used, respectively. The total human
proteome was collected from the UniProt proteome repository (UP000005640).
The human disordered proteome was the collection of sequences predicted to be
disordered from the total human proteome. Proteins were predicted to be either
ordered or disordered with IUpred44. IUpred utilizes pairwise inter-residue
interaction energies to deﬁne the likelihood of order in a local region. Default
parameters were used to obtain both residue-speciﬁc probabilities of being ordered
and regions of predicted disorder. Both IUpred-predicted ordered and disordered
regions were collected and stored for later use with code written in Python
version 3.6.3.
Dipeptide frequency calculation. Composition is both the simplest and most
important feature of protein sequences. To understand the composition of the
disordered sequences, the frequency of each of the 400 dipeptides was analyzed
using various sets of proteins collected from the Gene Ontology Consortium or
other experimental datasets42,43,77. Collections were performed with BiomaRt
functions written in R version 4.3.3. The resulting FASTA ﬁles served as input for
the previously mentioned IUpred pipeline, in order to gather sequences predicted
to be disordered. Sequences with fewer than 50 residues were discarded and the
frequency of each dipeptide in the remaining sequences was measured. To analyze
differences between the composition of disordered sequences found within certain
sets of proteins, the logarithmic odds ratio (LOR, logarithm base 2) of each
dipeptide frequency was calculated. To obtain a dipeptide frequency, the counted
observations of each dipeptide was divided by the total number of observations.
The 20 × 20 matrix was initialized with a pseudo-count of one for each dipeptide.
Peptide synthesis. Lysine- (K2: (KKASL)2, K3: (KKASL)3) and arginine-rich
peptides (R2: (RRASL)2, R3: (RRASL)3) were synthesized with N-terminal Fmoc
protection group chemistry on a Libety1 (CEM) instrument, and puriﬁed by HPLC
(Reversed-phase, RP18, JASCO). The hybrid peptide K2R1 ((KKASL)2RRASL))
and peptides labeled with tetramethylrhodamine (TMR) at the N-terminus (TMR-
K3, TMR-K2R1, and TMR-R3) were synthesized as triﬂuoroacetic acids salts by
GenScript. Peptide stock solutions were made in nuclease-free water (Amresco).
Protein preparation. Tau proteins (hTau40, K25, and K1878) were expressed in
Escherichia coli strain BL21(DE3)78 from a pNG2 vector (a derivative of pET-3a,
Merck-Novagen, Darmstadt) in the presence of an antibiotic. In case of unlabeled
proteins, the cells were grown in 1–10 l LB and induced with 0.5 mM IPTG at
OD600 of 0.6–0.8. To obtain 15N-labeled protein, cells were grown in LB until an
OD600 of 0.6–0.8 was reached, then centrifuged at low speed, washed with M9 salts
(Na2HPO4, KH2PO4, and NaCl) and resuspended in minimal medium
M9 supplemented with 15NH4Cl as the only nitrogen source and induced with
0.5 mM IPTG. After induction, the bacterial cells were harvested by centrifugation
and the cell pellets were resuspended in lysis buffer (20 mM MES pH 6.8, 1 mM
EGTA, 2 mM DTT) complemented with protease inhibitor mixture, 0.2 mM
MgCl2, lysozyme and DNAse I. Subsequently, cells were disrupted with a French
pressure cell press (in ice cold conditions to avoid protein degradation). In the next
step, NaCl was added to a ﬁnal concentration of 500 mM and boiled for 20 min
making use of the heat stability of the protein. Denaturated proteins were removed
by ultracentrifugation at 127,000 × g for 40 min at 4 °C. The supernatant was then
put into dialysis tubings (3.5–5 kDa dialysis membrane from Spectra/Por) and
dialyzed overnight at 4 °C under constant stirring against dialysis buffer (20 mM
MES pH 6.8, 1 mM EDTA, 2 mM DTT, 0.1 mM PMSF, 50 mM NaCl) to remove
salt. The following day the sample was ﬁltered and applied onto a previously
equilibrated ion exchange chromatography column and the weakly bound proteins
were washed out with buffer A (same as dialysis buffer). Tau protein was eluted
with a linear gradient of 60% ﬁnal concentration of buffer B (20 mM MES pH 6.8,
1 M NaCl, 1 mM EDTA, 2 mM DTT, 0.1 mM PMSF). Protein samples were kept
and concentrated by ultraﬁltration (5 kDa Vivaspin from Sartorius) and puriﬁed by
gel ﬁltration chromatography. In the last step the protein was dialyzed against 25
mM Hepes pH 7.4, and ﬂash-frozen aliquots were stored. Protein concentrations
were determined using a BCA assay.
Liquid–liquid phase separation. If not stated otherwise, 1 mM of peptide in
50 mM HEPES, pH 7.4, was used and LLPS was induced by addition of polyuridylic
acid potassium salt (polyU RNA, MW= 600–1000 kDa, ~ 2000–3300 residues from
Sigma-Aldrich) or transfer RNA from baker’s yeast (tRNA, MW= 23–27 kDa,
~76–90 residues from Invitrogen by Thermo Fisher Scientiﬁc). In case of LLPS of
tau proteins (and if not stated otherwise), 50 µM of protein in 25 mM HEPES, pH
7.4, was mixed with cofactor: 125 µg ml−1 polyU RNA in case of K18, 100 µg ml−1
polyU RNA in case of K25, 40 µg ml−1 polyU RNA or 10% dextran (T500 from
Pharmacosmos) in case of hTau40. Experiments with tau proteins were performed
at room temperature in reducing conditions in the presence of 1 mM DTT to
prevent cysteine oxidation.
Peptide/protein acetylation. Peptides were acetylated using CREB (recombinant
hCREB binding protein (catalytic domain) from Enzo) and p300 (recombinant
hp300 binding protein (catalytic domain) from Enzo). The reaction was performed
by mixing 1 mM K3 with 0.62 µM CREB or p300, 1 mM AcCoA, 0.5 mM PMSF,
0.1 mM EDTA in 50 mM HEPES, pH 7.4. For acetylation of K18/hTau40, 50 µM of
the protein were mixed with 0.62 µM CREB, 1 mM AcCoA, 0.5 mM PMSF, 0.1 mM
EDTA, 1 mM DTT in 25 mM HEPES, pH 7.4. For efﬁcient acetylation, samples
were incubated at 30 °C for 2 h. To investigate the effect of acetylation on pre-
formed droplets, LLPS was induced by mixing K18 with 125 µg ml−1 polyU RNA,
hTau40 with 10% dextran or K3 with 1 mgml−1 polyU RNA, followed by enzyme
addition.
Labeling of proteins with ﬂuorescent dyes. K18, K25, and hTau40 were ﬂuor-
escently labeled on lysine residues using Alexa Fluor 488 Microscale Protein
Labeling Kit (Thermo Fisher Scientiﬁc) following vendor’s instructions. In case of
acetylated hTau40 (Ac-hTau40), the two native cysteine residues (C291, C322) of
hTau40 were used for attachment of a ﬂuorescent dye. Before labeling, hTau40 was
acetylated and the acetylation enzyme was removed by boiling the sample for 20
min followed by ultracentrifugation. The pellets (denatured enzymes) were
removed and the supernatant containing Ac-hTau40 was subjected to ﬂuorescent
labeling using Alexa Fluor 488 C5 Maleimide dye (Thermo Fisher Scientiﬁc). For
labeling, 15 moles of dye were used for each mole of protein. The proteins were
incubated in a light-protected Eppendorf tube with the dye freshly prepared in
dimethyl sulfoxide (DMSO) for 2 h at room temperature. Excess dye was removed
by passing the sample twice through a 0.5 ml 700 MWKO Zeba spin desalting
column (Thermo Fisher Scientiﬁc). For comparison, hTau40 was also labeled at the
two native cysteine residues. Prior to the labeling procedure, DTT was removed
from the buffer through dialysis using a slide-A-lyzer mini dialysis device (MWCO
3500, Thermo Fisher Scientiﬁc), followed by equilibration in 50 mM HEPES, pH
7.4, with 1 mM TCEP. The degree of labeling (DOL) was determined according to
the protocol described in Alexa Fluor 488 Microscale Protein Labeling Kit.
DIC and ﬂuorescence microscopy. DIC and ﬂuorescence images were acquired
using a Leica DM6000B microscope with a 63x objective (water immersion) and
processed using FIJI software (NIH)79. For imaging, unlabeled peptide/protein
samples were mixed with labeled TMR-labeled peptide (1 µM) or Alexa 488-labeled
protein (0.6 µM). At these concentrations, the labeled peptide/protein alone does
not form liquid droplets. To estimate the size of liquid droplets, 5–20 DIC images
were selected from different sample regions on the slide. Images were then analyzed
using FIJI (NIH) by measuring droplet diameters. Size distributions are displayed
as normalized frequency histograms.
Solution turbidity. Turbidity values of peptide and protein samples were deter-
mined at room temperature and a wavelength of 500 nm using a BioSpectrometer
Kinetic (Eppendorf) instrument. For samples without enzymes, polyU was the last
component added to the sample. In case of K18, the initial turbidity was too high
and samples were diluted three times prior to the time-dependent measurement of
the turbidity (Fig. 6d).
Fluorescence recovery after photobleaching. FRAP experiments were recorded
on a Leica TCS SP8 confocal microscope using 63x objective (oil immersion) and a
560-argon laser line. For FRAP measurements, liquid droplets were formed by
mixing 1 mM of peptide with 1 µM of TMR-labeled peptide and 1 mgml−1 of
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polyU RNA in 50 mM HEPES, pH 7.4, and 50 µM of the protein (hTau40 or K18)
with 0.6 µM Alexa 488-labeled protein, 1 mM DTT and 40 µg ml−1 polyU RNA. A
small region of interest (approx. 1.3 µm for the peptides and 0.6 µm in diameter for
the proteins) was chosen and bleached with 30 frames (peptides) or 5 frames
(proteins) of full laser power. Fluorescence recovery for the peptides was imaged at
low laser intensity of 0.7% and 160 frames were recorded with one frame per 170
ms. In case of the hTau40/K18, the laser intensity was set to 0.4% and 100 frames
were recorded with one frame per 1.29 s. Images were analyzed using FIJI (NIH)79.
FRAP recovery curves were processed, normalized and analyzed in Mathematica by
ﬁtting to an exponential recovery as well as the diffusion-controlled recovery model
by Axelrod et al.45 The Bayesian information criterion (BIC)80 was determined for
both models and used to select the most appropriate one. The model with the
lowest (i.e., more negative) value was selected. Three FRAP curves were averaged to
produce each FRAP curve for analyses.
NMR spectroscopy. NMR spectra of the peptides (K3 and R3) and polyU RNA
were acquired at 5 °C on Bruker 600 and 800MHz spectrometers equipped with
triple-resonance 5 mm cryogenic probes. Spectra were processed with TopSpin 3.5
(Bruker) and analyzed using Sparky81. One-dimensional 1H and two-dimensional
1H−13C heteronuclear single quantum coherence (HSQC) spectra were recorded at
natural abundance for uniformly dispersed K3 (1 mM K3 in 50 mM HEPES, 10%
D2O), K3 in liquid droplets (1 mM K3, 1 mgml−1 polyU RNA in 50 mM HEPES,
10% D2O) and polyU RNA (1 mgml−1 polyU RNA in 50 mM HEPES, 10% D2O).
2D 1H−1H TOtal Correlation SpectroscopY (TOCSY) was recorded to support
peptide peak-assignment. 1D 1H NMR spectra of R3 (1 mM R3 in 50 mM HEPES,
10% D2O) and R3 in liquid droplets (1 mM R3, 1 mgml−1 polyU RNA in 50 mM
HEPES, 10% D2O) were acquired additionally.
NMR titrations of hTau40 with tRNA were acquired at 5 °C on a Bruker 800
MHz spectrometer equipped with a triple-resonance 5 mm cryogenic probe. 2D
1H-15N HSQC spectra were recorded for the proteins (50 µM) with increasing
molar ratios of tRNA (0.25, 0.5 and 1) in 25 mM HEPES, pH 6.8 and 10% D2O.
15N-labeled hTAu40 was acetylated similar to the procedure described above. Here,
however, 6 mM AcCoA were used and the sample was incubated at 30 °C
overnight. Spectra were processed with TopSpin 3.5 (Bruker) and the peaks were
picked and analyzed using Sparky81. Chemical shift perturbations (CSP) of
individual residues were calculated according to CSP= [(δ1Hbound− δ1Hfree)2+
0.1(δ15Nbound− δ15Nfree)2]1/2, considering the relative dispersion of the proton and
nitrogen δ chemical shifts.
Mass spectrometry. Mass spectra of acetylated and unmodiﬁed peptides and
proteins were determined by liquid chromatography (Acquity Arc system, Waters)
combined with mass spectrometry (ZQ 4000 Single Quad D2, Alliance).
Semi-permeabilized cell assay. HeLa P4 cells82 were grown on poly-L-lysine
coated 12 mm coverslips (No 1.5), permeabilized with 0.003–0.005% digitonin in
TPB (20 mM HEPES pH 7.3–7.4, 110 mM KOAc, 2 mM Mg(OAC)2, 1 mM EGTA,
2 mM DTT and 1 µgml–1 each aprotinin, pepstatin and leupeptin). After several
stringent washes, nuclear pores were blocked by 15 min incubation with 200 µg
ml–1 wheat germ agglutinin (WGA) on ice. Cells were then incubated for 30 min at
room temperature in the absence (background control) or presence of 400 nM
recombinant/puriﬁed tau protein (K18, K25, hTau40, or Ac-hTau40) or 5 µM
TMR-labeled peptides, respectively, in TPB. Tau proteins to be compared quan-
titatively had similar DOL ( ± 3%) or were corrected to achieve similar DOLs by
mixing with unlabeled protein of the same concentration (“DOL corrected”). After
several stringent washes to remove non-bound protein, cells were ﬁxed and sub-
jected to immunoﬂuorescence for G3BP1 (Proteintech) and TIA-1 (Santa Cruz, C-
20; sc-1751) using Alexa 555 (Thermo Fisher Scientiﬁc) and Alexa 647-labeled
secondary antibodies (Thermo Fisher Scientiﬁc), respectively, to visualize SGs. Tia-
1 was stained using an Alexa 647-labeled secondary antibody (Thermo Fisher
Scientiﬁc), while G3BP1 was stained using either Alexa 488 (with TMR-labeled
peptides) or Alexa 555 (with tau proteins) secondary antibodies (Thermo Fisher
Scientiﬁc).
Immunostaining of SGs. For semi-permeabilized cell assays, cells were ﬁxed after
the last wash in 3.7% formaldehyde/PBS buffer for 7–10 min at room temperature
(RT) and permeabilized in 0.5% TX100/ PBS for 5 min at room temperature. Cells
were blocked for 10 min in blocking buffer (1% donkey serum in PBS/0.1% Tween-
20) and incubated with primary antibodies in blocking buffer for 1–2 h at RT or
overnight at 4 °C. Secondary antibodies were diluted in blocking buffer and
incubated for 45 min to 1 h at room temperature. Washing steps after antibody
incubation were performed with PBS/0.1% Tween-20. DNA was stained with DAPI
at 0.5 μg ml−1 in PBS and cells mounted in ProLong™ Diamond Antifade.
Confocal microscopy of SGs. Confocal microscopy was performed at the Bioi-
maging core facility of the Biomedical Center with an inverted Leica SP8 micro-
scope, equipped with lasers for 405, 488, 552, and 638 nm excitation. Images were
acquired using twofold frame averaging with a 63 × 1.4 oil objective, and an image
pixel size of 59 nm. The following ﬂuorescence settings were used for detection:
DAPI: 419–442 nm, Alexa 488: 498–530 nm or 533 nm, Alexa 555: 562–598 nm,
Alexa 647: 650–700 nm. Recording was performed sequentially to avoid bleed-
through. Alexa 488-labeled tau proteins and TMR-labeled peptides were recorded
with hybrid photo detectors (HyD) choosing laser settings for each comparison
individually to make best use of the dynamic range of the HyD and avoiding pixel
saturation. Dapi, Alexa 555 and Alexa 647 were recorded with a conventional
photomultiplier tube.
Image analysis and processing. Confocal images were acquired using LAS X
(Leica) and processed using Image J software applying linear enhancement for
brightness and contrast. At least 8–10 cells and a minimum of 25 SGs were imaged
per condition and replicate. For quantitative measurements, equal acquisition
settings and processing conditions for respective image sets were applied. For
display the raw ﬂuorescence intensity of tau proteins in SGs in the semi-
permeabilized cell assay, measured ﬂuorescence values were log transformed to
achieve a more balanced spread and displayed using Graph Prism 5.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1b, 1c, 2c, 2f, 5b, 6d, 6e, 8c, e and Supplementary
Figs 1b, 1c, 8a, b, 9 are provided as a Source Data ﬁle. Other data are available from the
corresponding author upon reasonable request.
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